ArticleBone marrow transplantation2021

Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation.

Jingsheng Hua et al.PubMed ↗Publisher ↗

No numbers read from the abstract.